Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/TX/Corpus Christi

Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Corpus Christi, TX

Q: How much do paid clinical trials in Corpus Christi pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Q: Do I need to be sick to join a clinical trial in Corpus Christi?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Q: Are clinical trials in Corpus Christi safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Q: Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

Q: How often do new paid studies open in Corpus Christi?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Corpus Christi.

Studies commonly pay $75 to $4,500 per completed study

65 clinical trials are currently recruiting participants within 30 miles of Corpus Christi. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

65studies recruiting

2+research centers nearby

4condition categories

Live from the NIH registry

Studies recruiting near Corpus Christi right now

Top 25 of 65 recruiting studies, sorted by proximity — each links to its official registry page

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 3 Interventional 2,150 participants sought

Akero Clinical Study Site — Corpus Christi, Texas (5.3 mi) · Sponsor: Akero Therapeutics, Inc

See eligibility & contact on ClinicalTrials.gov (NCT06528314)

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Obesity, Overweight Phase 3 Interventional 125 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06672549)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02402244)

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Growth Hormone Deficiency (GHD) Phase 3 Interventional 150 participants sought

Lumos Pharma Investigational Site — Corpus Christi, Texas (5.3 mi) · Sponsor: Lumos Pharma

See eligibility & contact on ClinicalTrials.gov (NCT06948214)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome Phase 3 Interventional 2,000 participants sought

Research Site — Corpus Christi, Texas (5.3 mi) · Sponsor: DalCor Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT05918861)

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

Non-infected Venous Leg Ulcer, Venous Leg Ulcer N/A Interventional 60 participants sought

Site 38 — Corpus Christi, Texas (5.3 mi) · Sponsor: BioStem Technologies

See eligibility & contact on ClinicalTrials.gov (NCT06811909)

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 2 Interventional 180 participants sought

Pinnacle Clinical Research - Corpus Christi — Corpus Christi, Texas (5.3 mi) · Sponsor: Rivus Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07491458)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06172296)

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Pain N/A Observational 4,800 participants sought

Institute of Precision Pain Medicine — Corpus Christi, Texas (5.3 mi) · Sponsor: Boston Scientific Corporation

See eligibility & contact on ClinicalTrials.gov (NCT01719055)

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Systemic Lupus Erythematosus (SLE) N/A Observational 223 participants sought

Arthritis Care of Texas - Corpus Christi — Corpus Christi, Texas (5.3 mi) · Sponsor: Bristol-Myers Squibb

See eligibility & contact on ClinicalTrials.gov (NCT07175285)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought

89bio Clinical Study Site — Corpus Christi, Texas (5.3 mi) · Sponsor: 89bio, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06318169)

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Phase 3 Interventional 556 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT07022678)

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Overweight, Obesity Phase 3 Interventional 1,035 participants sought

Private Practice - Dr. Osvaldo A. Brusco — Corpus Christi, Texas (5.3 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT07282600)

North American Comfilcon A Clinical Study

Astigmatism, Presbyopia N/A Observational 182 participants sought

Drs. McIntyre, Garza, Avila and Jurica, Optometrists — Corpus Christi, Texas (5.3 mi) · Sponsor: CooperVision International Limited (CVIL)

See eligibility & contact on ClinicalTrials.gov (NCT06902584)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT05382338)

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma Phase 2 Interventional 160 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT04684368)

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

Invasive Fungal Infection Phase 2 Interventional 40 participants sought

Driscoll Children's Hospital ( Site 2113) — Corpus Christi, Texas (5.3 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT04665037)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05675410)

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Obesity, Weight Gain Phase 3 Interventional 300 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06439277)

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Sjögren´s Disease Phase 3 Interventional 570 participants sought

Arthritis Care of Texas — Corpus Christi, Texas (5.3 mi) · Sponsor: Novartis Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07621809)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia Phase 2 Interventional 153 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06317662)

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Multiple conditions Phase 3 Interventional 1,780 participants sought

Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT03067181)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought

Akero Clinical Study Site — Corpus Christi, Texas (5.3 mi) · Sponsor: Akero Therapeutics, Inc

See eligibility & contact on ClinicalTrials.gov (NCT06215716)

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) Phase 3 Interventional 202 participants sought

Arthritis Care of Texas — Corpus Christi, Texas (5.3 mi) · Sponsor: EMD Serono Research & Development Institute, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07332481)

Actively enrolling

Studies you may be able to join near Corpus Christi

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Corpus Christi

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

South Texas Clinical Research

★ 4.4

1010 Ohio Ave, Corpus Christi, TX 78404

(361) 288-4668

Website

"Fast and professional. Never an issue."

— ily sil, 5★

Pinnacle Clinical Research

★ 5.0

1521 S Staples St Ste 803, Corpus Christi, TX 78404

(361) 400-5352

Website

"I love this place! Staff is friendly and professional, they were good at explaining everything to me so i understand all of it. I would definitely re…"

— andrea landa, 5★

Clinical trials in Corpus Christi: what's recruiting

The Corpus Christi area currently has 65 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Corpus Christi, the most active research areas are:

Cancer & Oncology9 studies
Diabetes & Metabolism6 studies
Liver & Kidney5 studies
Immune & Skin2 studies

Every listing shows the study phase, the recruiting site and its distance from Corpus Christi, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Corpus Christi

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Corpus Christi participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Corpus Christi pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Corpus Christi?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Corpus Christi safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

How often do new paid studies open in Corpus Christi?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Corpus Christi.

Paid clinical trials near Corpus Christi

Other metros within reach

Brownsville, TX63 McAllen, TX139 San Antonio, TX1,010 Laredo, TX22 Austin, TX738 Houston, TX3,069 Galveston, TX204 Pasadena, TX3,010

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Corpus Christi Bladder Issues Due To Spinal Cord Injury in Corpus Christi All conditions

More of TX

Houston3,069 Pasadena3,010 Irving1,988 Grand Prairie1,956 Arlington1,871 Dallas1,868 Garland1,830 Plano1,825 Frisco1,824 Mesquite1,771 San Antonio1,010 Austin738

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts